Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma
Abstract Nasopharyngeal carcinoma (NPC) is an Epstein–Barr virus (EBV)-associated heterogeneous disease and is characterized by peritumoral immune infiltrate. Adoptive T-cell therapy (ACT) has emerged as a potential therapeutic strategy for NPC. However, the tumor microenvironment remains a major ro...
Saved in:
Main Authors: | Corey Smith, Margaret McGrath, Michelle A. Neller, Katherine K. Matthews, Pauline Crooks, Laetitia Le Texier, Benedict Panizza, Sandro Porceddu, Rajiv Khanna |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/2ff4c31e55df41fc9e1e70e5cbd4cff1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EBV based cancer prevention and therapy in nasopharyngeal carcinoma
by: Ya Cao
Published: (2017) -
Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy.
by: Jiang Li, et al.
Published: (2007) -
Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma
by: Weitao Lin, et al.
Published: (2018) -
EBV Positive Aggressive NK-Cell Leukemia
by: Ankitha Hebbar, et al.
Published: (2021) -
Potential Biomarkers for the Efficacy of PD-1-PD-L Blockade in Cancer
by: Grecea M, et al.
Published: (2021)